Filtros de búsqueda

Lista de obras de Thomas Nerreter

Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expression

artículo científico publicado en 2014

CAR T-cells targeting FLT3 have potent activity against FLT3-ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib

artículo científico publicado en 2018

CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation

scientific article published on 01 October 2020

Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell Platform

artículo científico publicado en 2018

Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro

artículo científico publicado en 2013

Dasatinib enhances migration of monocyte-derived dendritic cells by reducing phosphorylation of inhibitory immune receptors Siglec-9 and Siglec-3.

artículo científico publicado en 2014

Differential effects of the oncogenic BRAF inhibitor PLX4032 (vemurafenib) and its progenitor PLX4720 on ABCB1 function.

artículo científico publicado en 2014

Karanjin interferes with ABCB1, ABCC1, and ABCG2.

artículo científico publicado en 2014

Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility

artículo científico

Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia.

artículo científico publicado en 2018

ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models

artículo científico publicado en 2019

Robust 8-color flow cytometry panel reveals enhanced effector function of NKG2C+ CD57+ FcεRγ- NK cells in CMV seropositive human blood donors

artículo científico publicado en 2017

Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose- and time-dependent manner.

artículo científico publicado en 2018

Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T

scientific article published on 17 July 2019

The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells

scientific article published on 01 July 2019

Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab

scientific article published on 29 April 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda